ホームへ

 英文雑誌

1. Deguchi, H., Deguchi, K., Tsukada, T., Wada, H., Kobayashi, T., Minami, N, Shirakawa, S., Kihira, H, and Tagawa, T:  Tooth extraction using a recombinant human factor VIII preparation (Bay W 6240) in a patient with hemophilia A. Curr Ther Res Clin Exp. 54, 389-394, 1993

2.  Deguchi H, Deguchi K, Tsukada T, Murashima S, Iwasaki E, Tsuda M, Kobayashi T, Shirakawa S: Long-term survival in a patient with malignant carcinoid treated with high-dose octreotide.  Intern.Med. 33:100-102, 1994

3.  Wada H, Wakita Y, Nakase T, Shimura M, Hiyoyama K, Nagaya S, Deguchi H, Mori Y, Kaneko T, Deguchi K, Fujii J, Shiku H: Increased plasma-soluble fibrin monomer levels in patients with disseminated intravascular coagulation.  Am.J.Hematol. 51:255-260, 1996

4.  Gabazza EC, Takeya H, Deguchi H, Sumida Y, Taguchi O, Murata K, Nakatani K, Yano Y, Mohri M, Sata M, Shima T, Nishioka J, Suzuki K: Protein C activation in NIDDM patients.  Diabetologia 39:1455-1461, 1996

5.  Gabazza EC, Takeya H, Deguchi H, Taguchi O, Wada H, Nishioka J, Shima T, Suzuki K: Acquired activated protein C resistance in patients with lupus anticoagulant and essential thrombocythemia.  Clin Appl Thromb HemDost 3:119-123, 1997

6.  Deguchi H, Takeya H, Gabazza EC, Nishioka J, Suzuki K: Prothrombin kringle 1 domain interacts with factor Va during the assembly of prothrombinase complex.  Biochem.J. 321:729-735, 1997

7.  Nakase T, Wada H, Wakita Y, Kaneko T, Deguchi H, Hiyoyama K, Shimura M, Mori Y, Shiku H: Plasma-activated factor VII level in patients positive for lupus anticoagulant.  Am.J.Hematol. 55:9-14, 1997

8.  Takeya H, Mori T, Gabazza EC, Kuroda K, Deguchi H, Matsuura E, Ichikawa K, Koike T, Suzuki K: Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids.  J.Clin.Invest. 99:2260-2268, 1997

9.  Deguchi H, Takeya H, Wada H, Gabazza EC, Hayashi N, Urano H, Suzuki K: Dilazep, an antiplatelet agent, inhibits tissue factor expression in endothelial cells and monocytes.  Blood 90:2345-2356, 1997

10. Suzuki, K. and Deguchi H: Adenosine receptor and platelet (Japanese).  Annual Review -Hematology-  12:196-202, 1998

11. Zhou H, Gabazza EC, Takeya H, Deguchi H, Urano H, Adachi Y, Suzuki K: Prothrombin and its derivatives stimulate motility of melanoma cells.  Thromb.Haemost. 80:407-412, 1998

12.  Deguchi H, Takeya H, Urano H, Gabazza EC, Zhou H, Suzuki K: Adenosine regulates tissue factor expression on endothelial cells.  Thromb.Res. 91:57-64, 1998

13. Shimura M, Wada H, Nakasaki T, Hiyoyama K, Mori Y, Nishikawa M, Deguchi H, Deguchi K, Gabazza EC, Shiku H: Increased truncated form of plasma tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.  Am.J.Hematol. 60:94-98, 1999

14. Okugawa Y, Wada H, Noda T, Sakakura M, Nakasaki T, Watanabe R, Deguchi H, Gabazza EC, Mori Y, Nishikawa M, Deguchi K, Nobori T, Shiku H. Increased plasma levels of tissue factor pathway inhibitor-activated factor X complex in patients with disseminated intravascular coagulation. Am J Hematol 65:210-4, 2000

15. Inoue A, Wada H, Takagi M, Yamamuro M, Mukai K, Nakasaki T, Shimura M, Hiyoyama K, Deguchi H, Gabazza EC, Mori Y, Nishikawa M, Deguchi K, Shiku H. Hemostatic abnormalities in patients with thrombotic complications on maintenance hemodialysis. Clin Appl Thromb Hemost 2000, 6:100-3

16. Deguchi H, Fernández JA, Hackeng TM, Banka CL, Griffin JH: Cardiolipin is a normal component of human plasma lipoproteins. Proc.Natl.Acad.Sci.U.S.A. 97, 1743-1748, 2000

17. Griffin JH, Deguchi H,  Fernández JA: Causes of thrombophilia yet to be discovered: A personal View. Haemostasis 2000, 30 (Suppl2): 26-33

18. Deguchi H,  Fernández JA, Pabinger I., Heit J.A., Griffin JH: Plasma glucosylceramide deficiency as potential risk factor for venous thrombosis and modulator of anticoagulant protein C pathway. Blood 2001, 97:1907-1914

19.Griffin JH,  Fernández JA, Deguchi H : Plasma lipoproteins, hemostasis and thrombosis. Thromb Hemost 2001, 86: 386-394